NO991655L - FremgangsmÕte for Õ inhibere stress-aktiverte-proteinkinaser - Google Patents
FremgangsmÕte for Õ inhibere stress-aktiverte-proteinkinaserInfo
- Publication number
- NO991655L NO991655L NO991655A NO991655A NO991655L NO 991655 L NO991655 L NO 991655L NO 991655 A NO991655 A NO 991655A NO 991655 A NO991655 A NO 991655A NO 991655 L NO991655 L NO 991655L
- Authority
- NO
- Norway
- Prior art keywords
- protein kinases
- activated protein
- inhibiting stress
- inhibiting
- stress
- Prior art date
Links
- 102000001253 Protein Kinase Human genes 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 108060006633 protein kinase Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2845996P | 1996-10-09 | 1996-10-09 | |
| PCT/US1997/018272 WO1998015272A1 (en) | 1996-10-09 | 1997-10-09 | Method for inhibiting stress-activated protein kinases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO991655D0 NO991655D0 (no) | 1999-04-08 |
| NO991655L true NO991655L (no) | 1999-06-08 |
Family
ID=21843560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO991655A NO991655L (no) | 1996-10-09 | 1999-04-08 | FremgangsmÕte for Õ inhibere stress-aktiverte-proteinkinaser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6214854B1 (ja) |
| EP (1) | EP0946172A4 (ja) |
| JP (1) | JP2002512591A (ja) |
| KR (1) | KR20000048967A (ja) |
| CN (1) | CN1157188C (ja) |
| AU (1) | AU4751897A (ja) |
| BR (1) | BR9712283A (ja) |
| CA (1) | CA2267967A1 (ja) |
| CZ (1) | CZ123099A3 (ja) |
| IL (1) | IL129326A0 (ja) |
| NO (1) | NO991655L (ja) |
| NZ (1) | NZ335080A (ja) |
| PL (1) | PL332638A1 (ja) |
| TR (1) | TR199900762T2 (ja) |
| WO (1) | WO1998015272A1 (ja) |
| ZA (1) | ZA979055B (ja) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2393488A1 (en) * | 1999-12-07 | 2001-06-14 | Duke University | Use of .alpha.1ar subtype-selective drugs in patients with acute myocardial infarction |
| US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| EP1499310A4 (en) * | 2002-04-30 | 2005-12-07 | Sb Pharmco Inc | MONOCITRATE MONOHYDRATE OF CARVEDILOL |
| KR101468827B1 (ko) * | 2002-06-27 | 2014-12-03 | 스미스클라인 비이참 (코르크) 리미티드 | 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법 |
| CA2492084A1 (en) * | 2002-06-27 | 2004-01-08 | Sb Pharmco Puerto Rico Inc. | Carvedilol hydobromide |
| US20070172446A1 (en) | 2003-05-16 | 2007-07-26 | Intermune, Inc. | Synthetic chemokine receptor ligands and methods of use thereof |
| AU2004281780B2 (en) | 2003-10-14 | 2009-03-19 | F. Hoffmann-La Roche Ltd | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication |
| WO2005040758A2 (en) * | 2003-10-24 | 2005-05-06 | Intermune, Inc. | Use of pirfenidone in therapeutic regimens |
| WO2005051325A2 (en) * | 2003-11-25 | 2005-06-09 | Sb Pharmco Puerto Rico Inc. | Carvedilol compositions methods of treatment and delivery |
| EP1686986A4 (en) * | 2003-11-25 | 2009-05-27 | Sb Pharmco Inc | CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT |
| WO2005051322A2 (en) * | 2003-11-25 | 2005-06-09 | Sb Pharmco Puerto Rico Inc. | Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts |
| JP2008513356A (ja) * | 2004-08-09 | 2008-05-01 | アリオス バイオファーマ インク． | 合成高度糖鎖付加プロテアーゼ耐性ポリペプチド変異体、それを使用する経口製剤および方法 |
| US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| WO2015031914A1 (en) * | 2013-08-30 | 2015-03-05 | Uti Limited Partnership | Store overload-induced calcium release inhibitors and methods for producing and using the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5405863A (en) | 1992-12-01 | 1995-04-11 | Smithkline Beecham Corporation | Antioxidant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| US5308862A (en) | 1993-03-05 | 1994-05-03 | Boehringer Mannheim Pharmaceuticals Corporation - Smithkline Beecham Corp., Ltd. Partnership No. 1 | Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
| US5393772A (en) * | 1993-11-24 | 1995-02-28 | Boehringer Mannheim Pharmaceuticals Corporation | Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation |
| US5760069A (en) * | 1995-02-08 | 1998-06-02 | Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 | Method of treatment for decreasing mortality resulting from congestive heart failure |
| US5643915A (en) * | 1995-06-06 | 1997-07-01 | Andrulis Pharmaceuticals Corp. | Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies |
-
1997
- 1997-10-09 JP JP51775498A patent/JP2002512591A/ja not_active Ceased
- 1997-10-09 CA CA002267967A patent/CA2267967A1/en not_active Abandoned
- 1997-10-09 AU AU47518/97A patent/AU4751897A/en not_active Abandoned
- 1997-10-09 PL PL97332638A patent/PL332638A1/xx unknown
- 1997-10-09 BR BR9712283-1A patent/BR9712283A/pt not_active Application Discontinuation
- 1997-10-09 NZ NZ335080A patent/NZ335080A/xx unknown
- 1997-10-09 IL IL12932697A patent/IL129326A0/xx unknown
- 1997-10-09 WO PCT/US1997/018272 patent/WO1998015272A1/en not_active Application Discontinuation
- 1997-10-09 TR TR1999/00762T patent/TR199900762T2/xx unknown
- 1997-10-09 ZA ZA979055A patent/ZA979055B/xx unknown
- 1997-10-09 KR KR1019990703015A patent/KR20000048967A/ko not_active Application Discontinuation
- 1997-10-09 EP EP97910045A patent/EP0946172A4/en not_active Withdrawn
- 1997-10-09 CZ CZ991230A patent/CZ123099A3/cs unknown
- 1997-10-09 CN CNB971804397A patent/CN1157188C/zh not_active Expired - Fee Related
-
1999
- 1999-04-08 NO NO991655A patent/NO991655L/no not_active Application Discontinuation
- 1999-12-08 US US09/456,866 patent/US6214854B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU4751897A (en) | 1998-05-05 |
| IL129326A0 (en) | 2000-02-17 |
| CN1157188C (zh) | 2004-07-14 |
| BR9712283A (pt) | 1999-08-31 |
| ZA979055B (en) | 1999-05-10 |
| PL332638A1 (en) | 1999-09-27 |
| CZ123099A3 (cs) | 1999-11-17 |
| KR20000048967A (ko) | 2000-07-25 |
| EP0946172A4 (en) | 2002-05-22 |
| US6214854B1 (en) | 2001-04-10 |
| NO991655D0 (no) | 1999-04-08 |
| EP0946172A1 (en) | 1999-10-06 |
| JP2002512591A (ja) | 2002-04-23 |
| TR199900762T2 (xx) | 1999-07-21 |
| CA2267967A1 (en) | 1998-04-16 |
| WO1998015272A1 (en) | 1998-04-16 |
| CN1239888A (zh) | 1999-12-29 |
| WO1998015272A8 (en) | 2000-03-23 |
| NZ335080A (en) | 2000-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2008015I1 (el) | Δικυκλικες ετepοαρωματικες ενωσεις σαν αναστολεις πρωτεϊνης κινασης τυροσινης | |
| DK0806474T3 (da) | Fremgangsmåde til at stabilisere drikkevarer | |
| DE69739418D1 (de) | System zur Herstimulussteuerung | |
| NO20001748L (no) | FremgangsmÕte for Õ modulere serin/treonin proteinkinasefunksjon med 5-azaquinoksalin-baserte forbindelser | |
| NO983405L (no) | Fremgangsmåte for ökning av smöreevnen til snöskigrunnflater | |
| NO983892D0 (no) | Inhibitorer for farnesyl-proteintransferase | |
| PT927183E (pt) | Inibidores espirociclicos de metaloproteases | |
| NO20010117L (no) | Fremgangsmåte for behandling av sövnlöshet | |
| NO991655D0 (no) | FremgangsmÕte for Õ inhibere stress-aktiverte-proteinkinaser | |
| ATE205836T1 (de) | Bicyclische 4-aralkylaminopyrimidin-derivate als tyrosinkinase-inhibitoren | |
| FI951514A (fi) | Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita | |
| DE69700801D1 (de) | Verfahren zur Kopositionierung von Satelliten | |
| IS5742A (is) | Aðferð til genalækninga | |
| DK0987356T3 (da) | Fremgangsmåde til trækning | |
| DE69737237D1 (de) | Verfahren zur trockenätzung | |
| ID18300A (id) | Metoda penemperan | |
| IT1283794B1 (it) | Metodo per la rimozione di acqua da superfici | |
| FI960534A (fi) | Menetelmä analyyttien ei-kilpailevaa määritystä varten | |
| DK0912446T3 (da) | Fremgangsmåde til behandling af vand | |
| ATE218559T1 (de) | Verfahren zur monoacylierung von hydroxytaxanen | |
| UA25728A (uk) | Спосіб одержаhhя сорбеhту для очистки меляси | |
| IT1294014B1 (it) | Metodo di applicazione per fangoterapia | |
| DK1084215T3 (da) | Fremgangsmåde til fraktionering | |
| UA25353A (uk) | Спосіб холецистостомії | |
| UA25135A (uk) | Спосіб гастроєюhопластики |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |